Insider Trading Activity Pfizer Inc. (NYSE:PFE) – Insider Sold 13,986 shares of Stock

ME Staff
-
0

Insider Trading Activity For Pfizer Inc. (NYSE:PFE)

Mikael Dolsten , Insider of Pfizer Inc. (NYSE:PFE) reportedly Sold 13,986 shares of the company’s stock at an average price of 35.85 for a total transaction amount of $501,398.10 SEC Form

Insider Trading History For Pfizer Inc. (NYSE:PFE)

  • On 5/15/2013 Ian C Read, CEO, sold 69,900 with an average share price of $29.39 per share and the total transaction amounting to $2,054,361.00.
  • On 5/15/2013 Amy W Schulman, EVP, sold 70,000 with an average share price of $29.36 per share and the total transaction amounting to $2,055,200.00.
  • On 7/31/2013 Loretta V Cangialosi, VP, sold 14,688 with an average share price of $29.63 per share and the total transaction amounting to $435,205.44.
  • On 7/31/2013 Charles H Hill, EVP, sold 96,500 with an average share price of $29.64 per share and the total transaction amounting to $2,860,260.00.
  • On 9/16/2013 Freda Lewis-Hall, EVP, sold 38,461 with an average share price of $28.70 per share and the total transaction amounting to $1,103,830.70.
  • On 10/28/2013 Ian C Read, CEO, sold 338,000 with an average share price of $30.57 per share and the total transaction amounting to $10,332,660.00.
  • On 11/1/2013 Loretta V Cangialosi, VP, sold 10,000 with an average share price of $31.20 per share and the total transaction amounting to $312,000.00.

    • Analyst Ratings History For Pfizer Inc. (NYSE:PFE)

    • On 4/12/2016 S&P Equity Research Reiterated Rating Buy
    • On 5/4/2016 Independent Research Set Price Target of rating Neutral with a price target of $37.00
    • On 11/2/2016 Argus Downgraded rating Buy to Hold
    • On 12/2/2016 Guggenheim Initiated Coverage of rating Neutral
    • On 1/21/2017 Piper Jaffray Companies Set Price Target of rating Buy with a price target of $53.00
    • On 2/1/2017 Atlantic Securities Set Price Target of rating Buy with a price target of $37.00
    • On 5/16/2017 Citigroup Downgraded rating Neutral to Sell with a price target of $38.00 to $31.00

    Dividend Information For Pfizer Inc. (NYSE:PFE)
    Pfizer Inc. (NYSE:PFE) pays an annual dividend of $1.36 with a yield of 3.76% and an average dividend growth of 7.20% (3 Year Average).

    Dividend History For Pfizer Inc. (NYSE:PFE)

  • On 12/17/2012 Pfizer Inc. announced a quarterly dividend of $0.24 3.74% with an ex dividend date of 1/30/2013 which will be payable on 3/5/2013.
  • On 4/25/2013 Pfizer Inc. announced a quarterly dividend of $0.24 3.19% with an ex dividend date of 5/8/2013 which will be payable on 6/4/2013.
  • On 6/27/2013 Pfizer Inc. announced a quarterly dividend of $0.24 3.43% with an ex dividend date of 7/31/2013 which will be payable on 9/4/2013.
  • On 10/24/2013 Pfizer Inc. announced a quarterly dividend of $0.24 3.14% with an ex dividend date of 11/6/2013 which will be payable on 12/3/2013.
  • On 12/16/2013 Pfizer Inc. announced a quarterly dividend of $0.26 3.45% with an ex dividend date of 2/5/2014 which will be payable on 3/4/2014.
  • On 4/25/2014 Pfizer Inc. announced a quarterly dividend of $0.26 3.38% with an ex dividend date of 5/7/2014 which will be payable on 6/3/2014.
  • On 6/26/2014 Pfizer Inc. announced a quarterly dividend of $0.26 3.51% with an ex dividend date of 7/30/2014 which will be payable on 9/3/2014.

    • Recent Trading Activity for Pfizer Inc. (NYSE:PFE)
    Shares of Pfizer Inc. closed the previous trading session at with 35.77000045776367 shares trading hands.